Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01163682 · ClinicalTrials.gov registry record · NA

Electro-acupuncture for the Prevention of Taxane Induced Myalgias and Neuropathy

A NA study of Breast Cancer and Neuropathy, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
63
Enrollment target
1
Study location

NCT01163682 is a NA study of Breast Cancer and Neuropathy that has completed, run by Columbia University. The registered enrollment target is 63 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01163682, a NA study of Breast Cancer and Neuropathy, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
63 participants
Enrollment target
1
Study location

Study Summary

This study seeks to determine if 12 weeks of weekly electro-acupuncture will prevent or decrease neuropathic pain in breast cancer patients receiving 12 weekly treatments of taxane treatment.

Conditions Studied

Interventions

  • DEVICE Electro-acupuncture
  • DEVICE Sham acupuncture

Study Locations (1)

New York

  • Columbia University Medical Center - New York

Trial Details

FieldValue
Enrollment Target 63 participants
Start Date 2010-12
Est. Completion 2017-05
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT01163682

The ClinicalTrials.gov registry entry for NCT01163682 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Electro-acupuncture is the first listed.

NCT01163682 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01163682 about?

NCT01163682 is a clinical study titled "Electro-acupuncture for the Prevention of Taxane Induced Myalgias and Neuropathy". This study seeks to determine if 12 weeks of weekly electro-acupuncture will prevent or decrease neuropathic pain in breast cancer patients receiving 12 weekly treatments of taxane treatment.

What is the current status of trial NCT01163682?

This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2010-12. Estimated completion is 2017-05.

What conditions does trial NCT01163682 study?

This clinical trial studies the following conditions: Breast Cancer, Neuropathy.

What interventions are being tested in trial NCT01163682?

The interventions under investigation include: Electro-acupuncture (DEVICE), Sham acupuncture (DEVICE).

Who is sponsoring clinical trial NCT01163682?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01163682 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.